Cargando…

Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility

BACKGROUND: Oestrogen receptor (ER) signalling-dependent cancer cell growth is one of the major features of ER-positive breast cancer (BC). Inhibition of ER function is a standard and effective treatment for ER-positive tumours; however, ~20% of patients with ER-positive BC experience early or late...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumegawa, Kohei, Saeki, Sumito, Takahashi, Yoko, Yang, Liying, Osako, Tomo, Nakadai, Tomoyoshi, Amino, Sayuri, Maeda, Tetsuyo, Takahata, Chikako, Mori, Seiichi, Noda, Tetsuo, Ohno, Shinji, Ueno, Takayuki, Maruyama, Reo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050410/ https://www.ncbi.nlm.nih.gov/pubmed/36725920 http://dx.doi.org/10.1038/s41416-023-02178-1

Ejemplares similares

Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility
por: Kumegawa, Kohei, et al.
Publicado: (2023)

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer
por: Kumegawa, Kohei, et al.
Publicado: (2022)

Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening
por: Nakadai, Tomoyoshi, et al.
Publicado: (2022)

Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin
por: Saeki, Sumito, et al.
Publicado: (2023)

FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer
por: Kumegawa, Kohei, et al.
Publicado: (2023)

Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample
por: Yoshida, Reiko, et al.
Publicado: (2021)

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer
por: Inoue, Yuka, et al.
Publicado: (2022)

Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment
por: Miyata, Kenichi, et al.
Publicado: (2023)

ER remodeling via ER-phagy
por: Gubas, Andrea, et al.
Publicado: (2022)

Dynamics of breast cancer relapse reveal late recurring ER-positive genomic subgroups
por: Rueda, Oscar M., et al.
Publicado: (2019)

ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
por: Choi, Young, et al.
Publicado: (2022)

Expression of ERβ, ERα and Her-2 and distribution of molecular subtypes in Uygur and Han patients with breast cancer
por: GUO, LIYING, et al.
Publicado: (2014)

Super-assembly of ER-phagy receptor Atg40 induces local ER remodeling at contacts with forming autophagosomal membranes
por: Mochida, Keisuke, et al.
Publicado: (2020)

ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk—Signaling Beyond (ER) Stress Response
por: Kumar, Vaishali, et al.
Publicado: (2021)

Eat it right: ER-phagy and recovER-phagy
por: Loi, Marisa, et al.
Publicado: (2018)

Targeting ER stress/ER stress response in myopathies
por: Zito, Ester
Publicado: (2019)

ER-Phagy and ER Stress Response (ERSR) in Plants
por: Zeng, Yonglun, et al.
Publicado: (2019)

ER-Phagy and Its Role in ER Homeostasis in Plants
por: Bao, Yan, et al.
Publicado: (2020)

ER-Phagy: A New Regulator of ER Homeostasis
por: Yang, Ming, et al.
Publicado: (2021)

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
por: Esserman, Laura J, et al.
Publicado: (2005)

Ltc1 is an ER-localized sterol transporter and a component of ER–mitochondria and ER–vacuole contacts
por: Murley, Andrew, et al.
Publicado: (2015)

Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest(™) 95GC Breast in a multi‑institutional registry study
por: Naoi, Yasuto, et al.
Publicado: (2023)

ER domains
por: LeBrasseur, Nicole
Publicado: (2005)

Vot-ER
por: Callaway, Jess
Publicado: (2021)

Sympathy for the Erring
Publicado: (1857)

Sympathy for the Erring
Publicado: (1875)

An Erring Witness
Publicado: (1876)

Sympathy for the Erring
Publicado: (1876)

A Role for Macro-ER-Phagy in ER Quality Control
por: Lipatova, Zhanna, et al.
Publicado: (2015)

COPII mitigates ER stress by promoting formation of ER whorls
por: Xu, Fang, et al.
Publicado: (2020)

Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease
por: Maity, Shuvadeep, et al.
Publicado: (2022)

ER-associated RNA silencing promotes ER quality control
por: Efstathiou, Sotirios, et al.
Publicado: (2022)

ESCRT-III-driven piecemeal micro-ER-phagy remodels the ER during recovery from ER stress
por: Loi, Marisa, et al.
Publicado: (2019)

Intratumoral heterogeneity, treatment response, and survival outcome of ER‐positive HER2‐positive breast cancer
por: Teruya, Natsuki, et al.
Publicado: (2023)

YAP inhibits ERα and ER(+) breast cancer growth by disrupting a TEAD-ERα signaling axis
por: Li, Xu, et al.
Publicado: (2022)

Er-O clustering and its influence on the lattice sites of Er in Si
por: Wahl, U, et al.
Publicado: (2003)

ER sliding dynamics and ER–mitochondrial contacts occur on acetylated microtubules
por: Friedman, Jonathan R., et al.
Publicado: (2010)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Widespread PERK-dependent repression of ER targets in response to ER stress
por: Gonen, Nir, et al.
Publicado: (2019)

BOK controls ER proteostasis and physiological ER stress responses in neurons
por: Walter, Franziska, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ejc3vqombkvc3eb4gi41ivf8m1